Synthetic organic

GSK2798745.

GSK2798745.

GSK2833503A.

GSK2833503A.

GSK2879552 is a selective, orally bioavailable, irreversible, mechanism-based inactivator of lysine-specific demethylase 1 (LSD1)/corepressor, with potential antineoplastic activity.

InformationGSK2981278 GSK2981278 is a highly potent and selective inverse agonist for RORγ .TargetsRORγIn vitroGSK2981278 has no significant effect on RORα-dependent activation. GSK2981278 significantly inhibits production of the Th17 signature

InformationGSK2981278 GSK2981278 is a highly potent and selective inverse agonist for RORγ .TargetsRORγIn vitroGSK2981278 has no significant effect on RORα-dependent activation. GSK2981278 significantly inhibits production of the Th17 signature

InformationGSK2981278 GSK2981278 is a highly potent and selective inverse agonist for RORγ .TargetsRORγIn vitroGSK2981278 has no significant effect on RORα-dependent activation. GSK2981278 significantly inhibits production of the Th17 signature

InformationGSK2981278 GSK2981278 is a highly potent and selective inverse agonist for RORγ .TargetsRORγIn vitroGSK2981278 has no significant effect on RORα-dependent activation. GSK2981278 significantly inhibits production of the Th17 signature

InformationGSK2981278 GSK2981278 is a highly potent and selective inverse agonist for RORγ .TargetsRORγIn vitroGSK2981278 has no significant effect on RORα-dependent activation. GSK2981278 significantly inhibits production of the Th17 signature

InformationGSK2982772 GSK2982772 is an ATP competitive receptor-interacting protein-1 (RIP1) kinase (RIPK1) inhibitor with the IC50 value of 16 nM. It has exquisite kinase specificity and excellent activity in blocking many TNF-dependent cellular

InformationGSK2982772 GSK2982772 is an ATP competitive receptor-interacting protein-1 (RIP1) kinase (RIPK1) inhibitor with the IC50 value of 16 nM. It has exquisite kinase specificity and excellent activity in blocking many TNF-dependent cellular